Latest News for: orsini

Edit

Orsini Selected as Specialty Pharmacy Partner for Cytokinetics's MYQORZO™ (aficamten)

Image Borger News-Herald 14 Jan 2026
MYQORZO is an FDA-approved oral therapy for the treatment of obstructive hypertrophic cardiomyopathy (oHCM) ....
Edit

Orsini Selected as Specialty Pharmacy Partner for ITVISMA® (onasemnogene abeparvovec-brve)

Image The Saline Courier 03 Dec 2025
ITVISMA is an FDA-approved intrathecal gene therapy for the treatment of spinal muscular atrophy ... .
  • 1
×